Safety and Efficacy of FIT039 for Verruca Vulgaris: A Placebo-Controlled, Phase I/II Randomized Controlled Trial.

Nomura T, Sumi E, Egawa G, Nakajima S, Toichi E, Inoue N, Shibuya M, Okamoto N, Mitsuishi T, Uozumi R, Tada H, Nakagawa T, Kusuba N, Okuno A, Shimizuhira C, Ishikawa M, Tanaka S, Hagiwara M, Kabashima K

Open source

DOI
10.1016/j.xjidi.2021.100026
Published
2021 Sep
Container
JID innovations : skin science from molecules to population health
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.xjidi.2021.100026,
  title = {Safety and Efficacy of FIT039 for Verruca Vulgaris: A Placebo-Controlled, Phase I/II Randomized Controlled Trial.},
  author = {Nomura T and Sumi E and Egawa G and Nakajima S and Toichi E and Inoue N and Shibuya M and Okamoto N and Mitsuishi T and Uozumi R and Tada H and Nakagawa T and Kusuba N and Okuno A and Shimizuhira C and Ishikawa M and Tanaka S and Hagiwara M and Kabashima K},
  year = {2021},
  journal = {JID innovations : skin science from molecules to population health},
  doi = {10.1016/j.xjidi.2021.100026},
  url = {https://doi.org/10.1016/j.xjidi.2021.100026}
}

RIS

TY  - JOUR
TI  - Safety and Efficacy of FIT039 for Verruca Vulgaris: A Placebo-Controlled, Phase I/II Randomized Controlled Trial.
AU  - Nomura T
AU  - Sumi E
AU  - Egawa G
AU  - Nakajima S
AU  - Toichi E
AU  - Inoue N
AU  - Shibuya M
AU  - Okamoto N
AU  - Mitsuishi T
AU  - Uozumi R
AU  - Tada H
AU  - Nakagawa T
AU  - Kusuba N
AU  - Okuno A
AU  - Shimizuhira C
AU  - Ishikawa M
AU  - Tanaka S
AU  - Hagiwara M
AU  - Kabashima K
PY  - 2021
JO  - JID innovations : skin science from molecules to population health
DO  - 10.1016/j.xjidi.2021.100026
UR  - https://doi.org/10.1016/j.xjidi.2021.100026
ER  - 

APA

T, N., E, S., G, E., S, N., E, T., N, I., M, S., N, O., T, M., R, U., H, T., T, N., N, K., A, O., C, S., M, I., S, T., M, H., & K, K. (2021). Safety and Efficacy of FIT039 for Verruca Vulgaris: A Placebo-Controlled, Phase I/II Randomized Controlled Trial.. JID innovations : skin science from molecules to population health. https://doi.org/10.1016/j.xjidi.2021.100026

Source records